AS1810722
Product Specifications
Target
Cytochromes P450|||STAT
Related Pathways
Metabolism|||JAK/STAT signaling|||Stem Cells
Purity
0.9913
Bioactivity
AS1810722, a fused bicyclic pyrimidine derivative, is an orally active and potent inhibitor of STAT6, demonstrating an IC50 of 1.9 nM. It exhibits effective inhibition of CYP3A4, positioning it as a promising candidate for research into allergic diseases, including asthma and atopic conditions.
Smiles
NC(=O)CN1CCN(CC1)c1ccc(Nc2ncc3ccn(Cc4cc(F)cc(F)c4)c3n2)cc1
Molecular Formula
C25H25F2N7O
Molecular Weight
477.51
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/51622A4D-428C-499E-AAE6-7CBC3E4EDE3F/T9043
CAS Number
909561-15-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
37354141 1x10<sup>6</sup> cells/1.0ml
PPIAP8 CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details 